Valuation : AVRA Medical Robotics, Inc.

Market Cap 683M 588M 552M 504M 947M 65.02B 954M 6.55B 2.55B 32.97B 2.57B 2.51B 109B P/E 2026 *
-56.8x
P/E 2027 * -56.8x
Enterprise Value 683M 588M 552M 504M 947M 65.02B 954M 6.55B 2.55B 32.97B 2.57B 2.51B 109B EV / Sales 2026 *
11.5x
EV / Sales 2027 * 8.97x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 51.19M
-0.16%-2.01%+0.88%+17.82% 49.81B
-1.11%-2.84%+420.04%+505.15% 44.06B
-0.21%+0.37%+36.88%+17.32% 42.99B
-1.95%-3.33%+8.29%+73.25% 40.88B
-0.94%-1.77%+18.34%+46.84% 33.11B
-1.11%-4.20%+25.49%+119.78% 16.58B
+6.10%+4.40% - - 17.27B
-0.11%-2.16%+11.54%+27.97% 14.63B
-1.12%-3.46%+76.50%+39.37% 13.76B
Average -0.34%-1.37%+74.75%+105.94% 30.34B
Weighted average by Cap. -0.27%-1.50%+88.84%+122.63%

Financials

2026 *2027 *
Net sales 59.6M 51.32M 48.18M 43.98M 82.63M 5.67B 83.22M 571M 222M 2.88B 224M 219M 9.52B 76.2M 65.61M 61.6M 56.23M 106M 7.25B 106M 730M 284M 3.68B 286M 280M 12.17B
Net income -12M -10.33M -9.7M -8.86M -16.64M -1.14B -16.76M -115M -44.73M -579M -45.06M -44.08M -1.92B -13M -11.19M -10.51M -9.59M -18.02M -1.24B -18.15M -125M -48.45M -627M -48.81M -47.75M -2.08B
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-